A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Dapsone Impurity 17 | CAS 90309-26-5 - Request Quote

Picture of Dapsone Impurity 17

Dapsone Impurity 17

SZ CAT No: SZ-D044021
CAS No
90309-26-5
Mol.F.
C12H10ClNO2S
Mol.Wt.
267.7
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Hazard Statement:

Usage Note:

Dapsone Impurity 17 is chemically 4-[(3-Chlorophenyl)sulfonyl] benzenamine. Dapsone Impurity 17 is supplied with detailed characterization data compliant with regulatory guideline. Dapsone Impurity 17 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dapsone.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 90309-26-5

Purchase 90309-26-5

Order 90309-26-5

Enquire 90309-26-5

price of 90309-26-5

90309-26-5 Supplier

90309-26-5 Manufacturer

90309-26-5 Exporter

buy high quality Dapsone Impurity 17

Purchase Dapsone Impurity 17

Dapsone Impurity 17 suppliers

Dapsone Impurity 17 manufacturers

Dapsone Impurity 17 price

Order Dapsone Impurity 17

Enquire Dapsone Impurity 17

Dapsone Impurity 17 cost

Dapsone Impurity 17 Supplier

Dapsone Impurity 17 Distributor

Dapsone Impurity 17 for Method Validation

Dapsone Reference Standard

Dapsone Impurity 17 for ANDA Filing

Dapsone Impurity 17 for Forced Degradation Studies

Dapsone Impurity 17 Identification Standards

Dapsone Impurity 17 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,